COMMUNIQUÉS West-GlobeNewswire
-
Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock
21/08/2024 - 22:05 -
LifeStance to Present at the 22nd Annual Morgan Stanley Healthcare Conference
21/08/2024 - 22:10 -
Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment
21/08/2024 - 22:11 -
Globus Medical Launches ADIRA™ XLIF™ Plate System
21/08/2024 - 22:15 -
Certara to Participate in Upcoming Investor Conferences
21/08/2024 - 22:15 -
Integra LifeSciences Continues to Make Progress on Its ESG Strategy
21/08/2024 - 22:15 -
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21/08/2024 - 22:30 -
Algernon Pharmaceuticals Announces Closing of Private Placement
20/08/2024 - 13:00 -
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication
20/08/2024 - 13:00 -
Infectious Disease Expert Kelly Warfield Named Sabin’s New R&D President
20/08/2024 - 13:00 -
The Joint Corp. to Participate in the 7th Annual B. Riley Securities Consumer & TMT Conference
20/08/2024 - 13:05 -
LAVA Reports Second Quarter 2024 Financial Results and Business Update
20/08/2024 - 13:30 -
Incyclix Bio Appoints Dr. Andrew Beelen as Vice President of Clinical Development
20/08/2024 - 13:30 -
Opus Genetics Receives Rare Pediatric Disease Designation from the U.S. FDA for Ocular Gene Therapy OPGx-LCA5 to Treat Rare Inherited Retinal Disease LCA5
20/08/2024 - 14:00 -
Avadel Pharmaceuticals Announces Publication in Clinical Therapeutics of Data Highlighting Weight Loss in People with Narcolepsy Treated with LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension
20/08/2024 - 14:00 -
Immutep Announces Late-Breaking Abstract in Head & Neck Cancer Selected for Oral Presentation at ESMO Congress 2024
20/08/2024 - 14:00 -
Entera Bio to Participate in Upcoming Investor and Scientific Conferences
20/08/2024 - 14:00 -
Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update
20/08/2024 - 14:00 -
Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
20/08/2024 - 14:00
Pages